The Exocrine Pancreatic Insufficiency Market is expected to gain market growth at a healthy CAGR 6% from USD 2.13 Billion to USD 3.62 Billion in the forecast period of 2022 to 2028. Exocrine pancreatic insufficiency (EPI) is a condition in which the pancreas cannot digest food properly due to insufficient levels of digestive enzymes. EPI […]
